D.E. Shaw & Co
USNA icon

D.E. Shaw & Co’s Usana Health Sciences USNA Stock Holding History

D.E. Shaw & Co’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.19M Sell
182,483
-20,103
-10% -$399K ﹤0.01% 2534
2025
Q4 		$3.98M Buy
202,586
+152,016
+301% +$3.15M ﹤0.01% 2496
2025
Q3 		$1.39M Sell
50,570
-25,046
-33% -$771K ﹤0.01% 3234
2025
Q2 		$2.31M Sell
75,616
-71,032
-48% -$2.02M ﹤0.01% 2636
2025
Q1 		$3.96M Sell
146,648
-61,136
-29% -$1.94M ﹤0.01% 2077
2024
Q4 		$7.46M Sell
207,784
-2
-0% -$75 0.01% 1694
2024
Q3 		$7.88M Buy
207,786
+2,331
+1% +$95.8K 0.01% 1595
2024
Q2 		$9.29M Buy
205,455
+32,246
+19% +$1.48M 0.01% 1383
2024
Q1 		$8.4M Buy
173,209
+6,206
+4% +$304K 0.01% 1493
2023
Q4 		$8.95M Buy
167,003
+20,027
+14% +$1.01M 0.01% 1451
2023
Q3 		$8.61M Sell
146,976
-12,723
-8% -$796K 0.01% 1392
2023
Q2 		$10.1M Sell
159,699
-11,961
-7% -$762K 0.01% 1337
2023
Q1 		$10.8M Sell
171,660
-5,514
-3% -$329K 0.01% 1304
2022
Q4 		$9.43M Buy
177,174
+5,897
+3% +$319K 0.01% 1491
2022
Q3 		$9.6M Sell
171,277
-6,264
-4% -$414K 0.01% 1382
2022
Q2 		$12.8M Buy
177,541
+4,288
+2% +$319K 0.02% 1191
2022
Q1 		$13.8M Sell
173,253
-8,078
-4% -$728K 0.01% 1308
2021
Q4 		$18.4M Sell
181,331
-29,422
-14% -$2.93M 0.02% 1142
2021
Q3 		$19.4M Sell
210,753
-2,879
-1% -$277K 0.02% 1030
2021
Q2 		$21.9M Sell
213,632
-8,836
-4% -$887K 0.02% 967
2021
Q1 		$21.7M Buy
222,468
+29,318
+15% +$2.67M 0.02% 880
2020
Q4 		$14.9M Sell
193,150
-18,613
-9% -$1.44M 0.01% 1118
2020
Q3 		$15.6M Sell
211,763
-54,700
-21% -$4.39M 0.02% 970
2020
Q2 		$19.6M Sell
266,463
-40,523
-13% -$3.18M 0.02% 788
2020
Q1 		$17.7M Sell
306,986
-66,900
-18% -$4.65M 0.03% 686
2019
Q4 		$29.4M Buy
373,886
+31,296
+9% +$2.31M 0.03% 621
2019
Q3 		$23.4M Buy
342,590
+71,147
+26% +$4.78M 0.03% 702
2019
Q2 		$21.6M Buy
271,443
+31,396
+13% +$2.49M 0.03% 707
2019
Q1 		$20.1M Buy
240,047
+126,466
+111% +$13.2M 0.03% 725
2018
Q4 		$13.4M Sell
113,581
-774
-0.7% -$89.5K 0.02% 915
2018
Q3 		$13.8M Buy
114,355
+34,757
+44% +$4.31M 0.02% 947
2018
Q2 		$9.18M Buy
79,598
+4,508
+6% +$493K 0.01% 1128
2018
Q1 		$6.45M Buy
75,090
+6,226
+9% +$482K 0.01% 1252
2017
Q4 		$5.1M Buy
68,864
+4,996
+8% +$334K 0.01% 1478
2017
Q3 		$3.69M Buy
63,868
+2,662
+4% +$157K 0.01% 1605
2017
Q2 		$3.92M Buy
61,206
+2,707
+5% +$167K 0.01% 1529
2017
Q1 		$3.37M Sell
58,499
-14,877
-20% -$888K 0.01% 1534
2016
Q4 		$4.49M Buy
73,376
+13,700
+23% +$893K 0.01% 1421
2016
Q3 		$4.13M Sell
59,676
-41,636
-41% -$2.75M 0.01% 1419
2016
Q2 		$5.64M Buy
101,312
+86,460
+582% +$5.21M 0.01% 1210
2016
Q1 		$902K Sell
14,852
-45,512
-75% -$2.68M ﹤0.01% 2418
2015
Q4 		$3.86M Sell
60,364
-49,992
-45% -$3.24M 0.01% 1612
2015
Q3 		$7.4M Sell
110,356
-92,338
-46% -$6.53M 0.01% 1144
2015
Q2 		$13.8M Buy
202,694
+10,782
+6% +$684K 0.02% 822
2015
Q1 		$10.7M Buy
191,912
+43,392
+29% +$2.22M 0.02% 930
2014
Q4 		$7.62M Buy
148,520
+139,468
+1,541% +$6.85M 0.01% 1277
2014
Q3 		$333K Sell
9,052
-86,784
-91% -$3.13M ﹤0.01% 3626
2014
Q2 		$3.74M Sell
95,836
-20,072
-17% -$745K 0.01% 1823
2014
Q1 		$4.37M Sell
115,908
-11,554
-9% -$404K 0.01% 1702
2013
Q4 		$4.82M Sell
127,462
-15,692
-11% -$600K 0.01% 1706
2013
Q3 		$6.21M Buy
143,154
+2,986
+2% +$120K 0.01% 1397
2013
Q2 		$5.07M Buy
+140,168
New +$4.26M 0.01% 1344

Other funds holding USNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

D.E. Shaw & Co's USNA Position: Q1 2026 in Review

D.E. Shaw & Co reduced its Usana Health Sciences (USNA) stake by 9.9% in Q1 2026, selling an estimated $399K and leaving 182,483 shares worth $3.19M. The position accounts for ﹤0.01% of the portfolio, ranked #2534.

D.E. Shaw & Co first reported a position in USNA in Q2 2013 and has held it in 52 quarters since. The position peaked at $29.4M in Q4 2019. 139 funds tracked by Wall St. Rank hold USNA as of Q1 2026.

  • D.E. Shaw & Co held 182,483 shares of Usana Health Sciences worth $3.19M as of Q1 2026.
  • D.E. Shaw & Co sold 20,103 Usana Health Sciences shares in Q1 2026, an estimated $399K.
  • Usana Health Sciences made up ﹤0.01% of D.E. Shaw & Co's portfolio in Q1 2026, its #2534 holding.
  • D.E. Shaw & Co first reported a position in Usana Health Sciences in Q2 2013 and has held it in 52 quarters since.
  • D.E. Shaw & Co's Usana Health Sciences position peaked at $29.4M in Q4 2019.
  • 139 funds tracked by Wall St. Rank held Usana Health Sciences as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.